Moran C A, Hochholzer L, Rush W, Koss M N
Department of Pulmonary and Mediastinal Pathology, Armed Forces Institute of Pathology, Washington, DC 20306-6000, USA.
Cancer. 1996 Dec 1;78(11):2328-33.
Primary intrapulmonary meningiomas are rare, and their occurrence has been reported in the literature only sporadically.
The clinical, pathologic, and immunohistochemical features of ten cases of primary intrapulmonary meningioma were reviewed.
The patients were 4 women and 6 men between the ages of 30 and 72 years (mean age: 51 years). In nine patients, the lung tumor was found during a routine chest radiographic study. The only patient with clinical symptomatology was a man who presented with a persistent cough of 45 days' duration. None of the patients had a previous history of central nervous system (CNS) meningioma or other tumor at the time of diagnosis. Macroscopically, the neoplasms were described as soft, white, well circumscribed lesions that ranged in size from 1.5 cm to 4 cm in greatest dimension. No predilection for any particular lobe or segment of lung was observed. Histologically, all the tumors showed the characteristic growth pattern of CNS meningiomas and were classified accordingly. Seven tumors were transitional meningiomas, and three were fibrous meningiomas. Psammoma bodies were observed in 50% of the tumors. Immunohistochemically, six cases showed positive staining for Epithelial Membrane Antigen (EMA) and vimentin, whereas two of these cases also showed focal positive staining for CD34. Clinical follow-up ranging from 1 month to 24 years was obtained for 6 patients. All the patients were alive and well except for 1 female who died 20 years after the initial diagnosis at age 92 of a cerebrovascular accident.
The clinical follow-up in this study suggests that these tumors are amenable to surgical resection, and when the tumor is resected in its entirety, the patient is cured. In addition, the immunohistochemical results suggest that, as in CNS meningiomas, EMA and vimentin are the most reliable immunologic markers for these tumors.
原发性肺内脑膜瘤罕见,文献中仅有零星报道。
回顾10例原发性肺内脑膜瘤的临床、病理及免疫组化特征。
患者年龄在30至72岁之间,女性4例,男性6例(平均年龄:51岁)。9例患者的肺部肿瘤在常规胸部X线检查时发现。唯一有临床症状的患者是一名男性,持续咳嗽45天。诊断时,所有患者既往均无中枢神经系统(CNS)脑膜瘤或其他肿瘤病史。大体上,肿瘤被描述为质地柔软、白色、边界清晰的病变,最大直径为1.5厘米至4厘米。未观察到对肺的任何特定叶或段有偏好。组织学上,所有肿瘤均显示CNS脑膜瘤的特征性生长模式,并据此分类。7例为过渡型脑膜瘤,3例为纤维型脑膜瘤。50%的肿瘤中可见砂粒体。免疫组化方面,6例上皮膜抗原(EMA)和波形蛋白染色阳性,其中2例CD34也呈局灶性阳性染色。6例患者获得了1个月至24年的临床随访。除1名女性在初次诊断20年后因脑血管意外于92岁死亡外,所有患者均存活且状况良好。
本研究的临床随访表明,这些肿瘤适合手术切除,当肿瘤完全切除时,患者可治愈。此外,免疫组化结果表明,与CNS脑膜瘤一样,EMA和波形蛋白是这些肿瘤最可靠的免疫标志物。